Kenya vs Nigeria: Access to anti-retroviral drugs, male
Kenya
84.0%
in 2024
Nigeria
84.0%
in 2024
Kenya rank
36th
Nigeria rank
36th
Access to anti-retroviral drugs, male over time
- Kenya
- Nigeria
How they compare
Kenya currently reports 84.0% against 84.0% in Nigeria, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Nigeria ahead.
Kenya ranks 36th and Nigeria ranks 36th of 141 countries.
Kenya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kenya | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.3% | 5.3% | 4.0% | Kenya |
| 2010s | 55.2% | 29.6% | 25.6% | Kenya |
| 2020s | 79.0% | 68.0% | 11.0% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Kenya or Nigeria?
- Kenya, at 84.0% against 84.0% in Nigeria as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Kenya and Nigeria?
- 0.0%, with Kenya ahead.
- How many years of comparable data are there for Kenya and Nigeria?
- 25 years are reported by both, from 2000 to 2024.
- How do Kenya and Nigeria rank globally for access to anti-retroviral drugs, male?
- Kenya ranks 36th and Nigeria ranks 36th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.